Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.0009 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |